Accessibility Menu
Diagnos logo

Diagnos

(TSXV) ADK

Current PriceCA$0.23
Market CapCA$28.30M
Since IPO (2000)-100%
5 Year-58%
1 Year+12%
1 Month+18%

Diagnos Financials at a Glance

Market Cap

CA$28.30M

Revenue (TTM)

CA$65.48K

Net Income (TTM)

-CA$4.56M

EPS (TTM)

-CA$0.04

P/E Ratio

-5.68

Dividend

CA$0.00

Beta (Volatility)

0.14 (Low)

Price

CA$0.23

Volume

88,770

Open

CA$0.24

Previous Close

CA$0.23

Daily Range

CA$0.22 - CA$0.24

52-Week Range

CA$0.18 - CA$0.42

Estimated Earnings Date

Aug 24, 2026

ADK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Diagnos

Industry

Health Care Technology

CEO

André M. Larente

Headquarters

Brossard, QC J4Z 1A7, CA

ADK Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-65%

Net Income Margin

-70%

Return on Equity

-990%

Return on Capital

-5%

Return on Assets

-2%

Earnings Yield

-17.61%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$28.30M

Shares Outstanding

120.41M

Volume

88.77K

Avg. Volume

217.27K

Financials (TTM)

Gross Profit

-CA$119.45K

Operating Income

-CA$4.26M

EBITDA

-CA$4.13M

Operating Cash Flow

-CA$4.00M

Capital Expenditure

-CA$11.06K

Free Cash Flow

-CA$4.01M

Cash & ST Invst.

CA$1.93M

Total Debt

CA$1.40M

Diagnos Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CA$15.71K

-14.6%

Gross Profit

CA$1.02M

+449.8%

Gross Margin

64.63%

N/A

Market Cap

CA$28.30M

N/A

Market Cap/Employee

CA$1.77M

N/A

Employees

16

N/A

Net Income

-CA$1.18M

+11.4%

EBITDA

-CA$1.15M

+0.2%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CA$1.93M

-40.4%

Total Debt

CA$1.40M

-54.4%

Accounts Receivable

CA$194.86K

+27.8%

Inventory

CA$0.00

N/A

Long Term Debt

CA$225.71K

-21.1%

Short Term Debt

CA$1.18M

-57.8%

Return on Assets

-1.91%

N/A

Return on Invested Capital

-4.67%

N/A

Free Cash Flow

-CA$1.31M

-5.7%

Operating Cash Flow

-CA$1.31M

-5.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVX.TOResverlogix Corp.
CA$0.09-10.00%
ROMJ.VRubicon Organics Inc.
CA$0.43-3.41%
LABS.TOMediPharm Labs Corp.
CA$0.07+0.00%
AVCN.TOAvicanna Inc.
CA$0.13+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$185.00-0.04%
NOKNokia
$13.49-0.02%
QSQuantumScape
$8.04+0.17%
FLEXFlex
$147.61+0.03%

Questions About ADK

What is the current price of Diagnos?

Diagnos is trading at CA$0.23 per share.

What is the 52-week range for Diagnos?

Over the past 52 weeks, Diagnos has traded between CA$0.18 and CA$0.42.

How much debt does Diagnos have?

As of the most recent reporting period, Diagnos reported total debt of CA$1.40M.

How much cash does Diagnos have on hand?

Diagnos reported CA$310.01K in cash and cash equivalents in its most recent financial results.

What is Diagnos’s dividend yield?

Diagnos does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.